The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2018
Filed:
Nov. 18, 2015
Applicants:
Commissariat À L'énergie Atomique ET Aux Énergies Alternatives, Paris, FR;
Institut National DE LA Sante ET DE LA Recherche Medicale, Paris, FR;
Inventors:
Fabrice Navarro y Garcia, Fontaine, FR;
Emilie Bayon, Grenoble, FR;
Patrice Marche, Meylan, FR;
Thomas Courant, Meylan, FR;
Assignees:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); C07K 16/18 (2006.01); A61K 47/62 (2017.01); A61K 47/69 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 47/62 (2017.08); A61K 47/6907 (2017.08); C07K 16/18 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55583 (2013.01); C07K 2317/10 (2013.01); C07K 2317/34 (2013.01);
Abstract
The application relates to an immunogenic composition comprising a continuous aqueous phase and at least two dispersed phases 1 and 2 as droplets, wherein the dispersed phase 1 comprises a surfactant 1 bearing an antigen and the dispersed phase 2 comprises an immunostimulating agent 2, to its preparation method and its uses, notably for producing antibodies, as a drug, as a vaccine or in an immunization method.